Reprint
Biomarkers in Neurodegenerative Diseases
Edited by
December 2022
190 pages
- ISBN978-3-0365-5729-8 (Hardback)
- ISBN978-3-0365-5730-4 (PDF)
This is a Reprint of the Special Issue Biomarkers in Neurodegenerative Diseases that was published in
Biology & Life Sciences
Medicine & Pharmacology
Summary
This book focuses on the recent advancements in both fundamental and clinical research, focusing on identifying, developing, and applying new and improved biological markers for specific neurologic disorders in the future.
The original research work and review articles published here highlight some unique mechanisms underlying the most prevalent pathophysiological conditions affecting human health. Other areas covered in the book include emerging treatment options and correct diagnoses using different biochemical and imaging techniques.
Format
- Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
Alzheimer’s disease; amyloid beta; hippocampus; Kir channels; K+ channels; glioblastoma multiforme; low-grade glioma; astrocytoma; recurrence; multifocal growth; mRNA expression; MPS1; TTK; therapy; EDTA chelation therapy; neurodegenerative diseases; metal detoxification; Alzheimer’s disease; reactive oxygen species (ROS); neuroinflammation; neurodegeneration; cognitive dysfunction; neurodegeneration; Alzheimer’s disease; neurofibrillary tangles; diagnosis methods; biomarkers; perinatal stress; NURR1; inflammation; late-onset diseases; early life; artificial neural network; deep learning; Parkinson’s disease; atypical parkinsonian syndrome; dopamine transporter SPECT; β-Amyloid; calpain; Collapsin Response Mediator Protein-2; human-neuroblastoma SH-SY5Y cells; Somatostatin-14; somatostatin receptor; brain injury; quinpirole; dopamine D2 receptors; glial cell; neuroinflammation; neurodegeneration; autophagy; mitophagy; neurodegeneration; multiple sclerosis; Alzheimer’s disease; Parkinson’s disease; biomarker; therapy; neurons; astrocytes; Alzheimer’s and Parkinson’s diseases; fluid and imaging biomarkers; amyloid-β and tau; miRNA; extracellular vesicles; exosomes and ectosomes; PET; radiotracers; radiolabeled molecules; n/a